The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreNov 2020
US$2,650Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Overall consumer health is expected to see a slightly slower current value growth rate in 2020 than seen in any other year of the review period. Although this is due to the COVID-19 outbreak in the country, categories are being impacted in very different ways.
As a result of COVID-19, the Indonesian borders closed to all foreigners without a work visa on 2 April, with various requirements in place for any arrivals. Commercial flights were restricted from 24 April to 7 June, with flights limited to 50% capacity and only certified business passengers permitted.
International players Kalbe Farma and Tempo Scan Pacific are expected to continue to lead consumer health in Indonesia in value terms in 2020, although this is a very fragmented industry, and no player accounts for a double-digit value share. These players offer numerous brands that enjoy a large consumer base throughout Indonesia, where they are known for their long-standing OTC brands such as Promag (Kalbe) and Bodrex (Tempo).
An interesting and important development in Indonesia in recent years was the rising number of healthcare start-ups offering online applications designed to give the country’s population better access to doctors, medical advice and other healthcare services. However, these really took off in the first half of 2020, as consumers were reluctant to visit a doctor or go to hospital for non-urgent matters, as they were concerned these were places where they were most likely to contract COVID-19.
Overall consumer health is expected to rebound to a higher current value growth rate in 2021. Although the rate of growth is then expected to gradually slow over the rest of the forecast period, the CAGR in the forecast period is expected to be higher than that seen in the review period.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Indonesia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Consumer Health industry in Indonesia, our research will save you time and money while empowering you to make informed, profitable decisions.
When you purchase this report, you also get the data and the content from these category reports in Indonesia for free:
The Consumer Health in Indonesia market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.